When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic IBD

By sjmartinez • July 16, 2024

Systrom HK, Rai V, Singh S, Baidoo L, Cheifetz AS, Devlin SM, Gecse KB, Irving PM, Kaplan GG, Kozuch PL, Ullman T, Sparrow MP, Melmed GY, Siegel CA. When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic IBD. Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002964. Epub ahead of print. PMID: 39008539.

Tags: Cedars Sinai DoM, Digestive Diseases, Publications

Related Posts

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Friedrich NA, Luu M, Gale R, Chaplin A, Polineni R, Shiang A, Shin D, Freedland SJ, Spiegel B, Ballas LK, Kokorowski P, Daskivich TJ. Are[...]

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies

Barry J, Abranches E, Baptista RP, Barry C, Brandsten C, Bruce K, Carpenter MK, Cavagnaro J, Collins L, Csaszar E, Dashnau J, de Villa D,[...]

Diagnostic Performance of F-18 Flurpiridaz in Women: A Sub-study of the Aurora Phase 3 Trial

Horgan SJ, Heller GV, Maddahi J, Bateman TM, Bax JJ, Beanlands RSB, Berman DS, Garcia EV, Somer E, Tamaki N, Thompson D, Udelson JE. Diagnostic[...]